Modine Manufacturing Posts Mixed Q4 Results, Joins Viasat, Lululemon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Author: Avi Kapoor | May 22, 2024 05:44am

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday.

Shares of Modine Manufacturing Company (NYSE:MOD) shares fell sharply in today’s pre-market trading following mixed fourth-quarter results.

Modine Manufacturing posted adjusted earnings of 77 cents per share, versus market estimates of 76 cents per share. The company's quarterly sales came in at $603.50 million compared to expectations of $605.36 million, according to data from Benzinga Pro.

Modine Manufacturing shares tumbled 8.8% to $92.50 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

LifeStance Health Group, Inc. (NASDAQ:LFST) shares tumbled 14.4% to $6.40 in pre-market trading. LifeStance Health Group priced its secondary public offering of 20 million common shares at $6.25 per share.
Viasat Inc (NASDAQ:VSAT) shares dipped 11.6% to $16.65 in pre-market trading after the company reported its fourth-quarter financial results.
Hudbay Minerals Inc. (NYSE:HBM) shares declined 8.8% to $9.44 in pre-market trading after the company announced a $300 million Bought Deal Equity Offering.
IAMGOLD Corporation (NYSE:IAG) shares fell 8% to $4.13 in pre-market trading after the company announced a $300 million bought deal financing.
Yatsen Holding Limited (NYSE:YSG) shares declined 6.2% to $4.27 in pre-market trading following downbeat second-quarter results.
Pharming Group N.V. (NASDAQ:PHAR) shares fell 6.2% to $8.90 in pre-market trading.
Lululemon Athletica Inc. (NASDAQ:LULU) shares declined 4.3% to $309.00 in pre-market trading after the company announces evolved structure of product and brand teams.
Bentley Systems, Incorporated (NASDAQ:BSY) shares fell 3.9% to $54.50 in pre-market trading.
Dyne Therapeutics, Inc. (NASDAQ:DYN) shares fell 3.5% to $31.50 in pre-market trading. Dyne Therapeutics priced $325.5 million public offering of 10.5 million common stock at $31 per share.
Vipshop Holdings Limited (NYSE:VIPS) shares declined 2.2% to $16.10 in pre-market trading following first-quarter results.